Mankind Pharma sets sights on Novo Nordisk's anti-obesity drug Semaglutide
The firm is focusing on specialty chronic therapies like immunotherapy, antibody-drug conjugates, and gene therapy drugs, ...
Ozempic play: Mankind Pharma in the fray for weight-loss drugs
Besides Mankind, Natco Pharma, Dr Reddy’s, Sun Pharma and others are already gearing up for launches of weight-loss drugs ...
Mankind Pharma develops oral anti-obesity drug, eyes global breakthrough
If successful, Mankind’s drug would be the first oral small-molecule alternative, offering a pill-based treatment.
Drug compounders sue FDA over semaglutide status: report
Makers of copycat versions of Novo Nordisk's (NVO) weight-loss drug semaglutide, also known as Ozempic and Wegovy, are suing ...
FiercePharma7d
Novo Nordisk's semaglutide shortage officially concludes in the US, spelling major threat for weight loss drug compounders
On Friday, the FDA reclassified the semaglutide shortage—which had covered multiple doses of Wegovy for obesity and Ozempic for type 2 diabetes—as "resolved" on its online drug shortage database.